All subjects underwent comprehensive ophthalmic examinations, including best-corrected visual acuity, Goldmann applanation tonometry, refraction tests, slit-lamp biomicroscopy, gonioscopy, stereodisc photography, and red-free fundus photography (EOS D60 digital camera; Canon Inc., Tokyo, Japan). Other examinations included measurements of corneal curvature (KR-1800 Auto Kerato-Refractometer; Topcon, Tokyo, Japan), central corneal thickness (Orbscan II; Bausch & Lomb, Rochester, NY, USA), and axial length (AXL) (IOLMaster V.5; Carl Zeiss Meditec, Jena, Germany); spectral-domain optical coherence tomography (SD-OCT) scanning of the circumpapillary RNFL and ONH in the enhanced depth imaging (EDI) mode (Spectralis; Heidelberg Engineering, Heidelberg, Germany); and standard automated perimetry (Humphrey Field Analyzer II 750 and 24-2 Swedish interactive threshold algorithm; Carl Zeiss Meditec).
The NAION group included subjects diagnosed at least 6 months prior to study entry. NAION diagnosis was based on the sudden, painless loss of visual acuity (VA) without history of glaucoma or retinal diseases, optic disc edema with or without superficial hemorrhages at the optic disc border and adjacent retina on fundus ophthalmoscopy, or VF defects consistent with NAION and with spontaneous resolution of optic disc edema within 2 to 3 months. Subjects were excluded if they showed symptoms or signs suggesting arteritic ischemic optic neuropathy or giant cell arteritis, such as jaw claudication, anorexia, unintended weight loss, and elevated erythrocyte sedimentation rate or reactive protein C levels. Subjects were also excluded if they had been diagnosed with glaucoma, had intraocular pressure (IOP) >21 mm Hg in either eye, or if the contralateral eye had features suspicious of or consistent with glaucoma.
NTG diagnosis was based on the presence of glaucomatous optic nerve damage (i.e., notching, neuroretinal rim thinning, and/or RNFL defects) with corresponding VF loss, open angle on gonioscopy, and IOP ≤ 21 mm Hg over multiple measurements during office hours (9 AM to 5 PM). A glaucomatous VF defect was defined as (1) a VF outside normal limits on the glaucoma hemifield test; (2) three abnormal points, each with a <5% probability (P) of being normal and one point with P < 1% by pattern deviation; or (3) a pattern standard deviation with P < 5% if the VF was otherwise normal, as confirmed in two consecutive tests. The VF results were deemed reliable when fixation losses were <20% and the false-positive and false-negative rates were each <25%. Moreover, subjects with NTG were required to have no history of IOP-lowering treatment. Healthy eyes were defined as those with no history of ocular symptoms, disease, or intraocular surgery except for uncomplicated cataract extraction. Normal eyes also had an IOP of ≤21 mm Hg, an absence of glaucomatous optic disc appearance, and no VF defect.
In each patient with NAION, either the superotemporal or inferotemporal sector of the eye affected by disease was selected as the sector of interest. If both sectors were affected, the more severely affected sector was selected based on RNFL thickness. NTG patients and healthy controls were selected by matching them 1:1:1 with NAION patients by age (within 5 years), IOP (within 1 mm Hg), AXL (within 1 mm), and optic disc area (ODA; within 1 mm2). NAION and NTG patients were also matched by RNFL thickness in the sector of interest (within 10 µm); the sector of interest in the healthy controls was the sector selected in the matched NAION patients. The ODA was measured by two experienced investigators (J.-A.K. and E.J.L.), who were masked to patient clinical information, using the built-in manual caliper tool designed to calculate the area of fundus images in Heidelberg Eye Explorer (software version 1.10.4.0, Heidelberg Engineering), a viewer program provided with the Spectralis OCT device. The final ODA was defined as the average of the two measurements, one made by each investigator.
Patients were excluded who had a spherical equivalent < –6.0 D or > +3.0 D; a cylinder correction < –3.0 D or > +3.0 D; a tilted disc (i.e., tilt ratio > 1.3 of the longest to the shortest diameter of the optic disc);
16,17 or a torted disc (i.e., a torsion angle deviation of the long axis of the optic disc from the vertical meridian > 15°).
17,18 Also excluded were patients with optic disc pallor from concomitant retinal diseases, such as diabetic retinopathy, retinal venous obstruction, retinal arterial obstruction, or retinitis pigmentosa, as well as those who had previously undergone unilateral cataract surgery to exclude pseudophakic pallor. The ovality index of the optic disc was defined as the ratio of the longest to the shortest disc diameters by the clinical optic disc margins on color photographs using ImageJ (National Institutes of Health, Bethesda, MD, USA). Eyes were also excluded if a good-quality image (i.e., quality score > 15) could not be obtained in more than five sections. If the quality score did not reach 15, the image-acquisition process automatically stopped or images of the respective sections were not obtained. LCD and the LCCI were measured only on acceptable scans with good-quality images that allowed clear delineation of the anterior borders of the LC within the range of the width of Bruch's membrane opening (BMO). IOP was measured on the same day that ONH was imaged by SD-OCT using the EDI technique.